Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-24-001752
Filing Date
2024-11-19
Accepted
2024-11-18 18:01:30
Documents
57
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bdpt_10q.htm   iXBRL 10-Q 806587
2 CERTIFICATION bdpt_ex311.htm EX-31.1 12858
3 CERTIFICATION bdpt_ex312.htm EX-31.2 10539
4 CERTIFICATION bdpt_ex321.htm EX-32.1 4092
5 CERTIFICATION bdpt_ex322.htm EX-32.2 4366
11 bdpt_10qimg2.jpg GRAPHIC 3803
  Complete submission text file 0001640334-24-001752.txt   3523675

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bdpt-20240930.xsd EX-101.SCH 36976
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdpt-20240930_lab.xml EX-101.LAB 211734
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bdpt-20240930_cal.xml EX-101.CAL 38995
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdpt-20240930_pre.xml EX-101.PRE 178701
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bdpt-20240930_def.xml EX-101.DEF 104756
60 EXTRACTED XBRL INSTANCE DOCUMENT bdpt_10q_htm.xml XML 426435
Mailing Address 2620 REGATTA DRIVE SUITE 102 LAS VEGAS NV 89128
Business Address 2620 REGATTA DRIVE SUITE 102 LAS VEGAS NV 89128 (702) 659-8829
BIOADAPTIVES, INC. (Filer) CIK: 0001575142 (see all company filings)

EIN.: 462592228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54949 | Film No.: 241472742
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)